Key result
Experimental rhinovirus challenge is linked to a loss of adaptive capacity in asthmatics.
Why the study?
Exaggerated physiological and inflammatory responses to exogenous triggers in asthma may be explained by disease-related systems instability and loss of adaptability to changing environmental conditions.
Does experimental rhinovirus infection reveal a loss of adaptive capacity in asthmatic patients compared to healthy volunteers?
Observational (n=24)
Does experimental rhinovirus infection reveal a loss of adaptive capacity in asthmatic patients compared to healthy volunteers?
p-value: p=0.029
Asthmatic patients demonstrate a loss of adaptive capacity following rhinovirus infection, suggesting that underlying biological instability contributes to loss of asthma control.
Time-series inflammatory marker fluctuations support systems instability in asthma; hypothesis-generating for dynamic monitoring before clinical adoption.
Asthma is a dynamic disease, in which lung mechanical and inflammatory processes interact in a complex manner, often resulting in exaggerated physiological, in particular, inflammatory responses to exogenous triggers. We hypothesize that this may be explained by respiratory disease-related systems instability and loss of adaptability to changing environmental conditions, manifested in highly fluctuating biomarkers and symptoms. Using time series of inflammatory (eosinophils, neutrophils, FeNO), clinical and lung function biomarkers (PEF, FVC,FEV 1 ), we estimated this loss of adaptive capacity (AC) during an experimental rhinovirus infection in 24 healthy and asthmatic human volunteers. Loss of AC was estimated by comparing similarities between pre- and post-challenge time series. Unlike healthy participants, the asthmatic’s post-viral-challenge state resembled more other rhinovirus-infected asthmatics than their own pre-viral-challenge state (hypergeometric-test: p=0.029). This reveals loss of AC and supports the concept that in asthma, biological processes underlying inflammatory and physiological responses are unstable, contributing to loss of control.
No takes yet. Share an insight, caveat, or question.
Sinha et al. (2019) conducted an observational in Asthma (n=24). Experimental rhinovirus challenge vs. Healthy participants was evaluated on Loss of adaptive capacity (similarity between pre- and post-challenge time series) (p=0.029). Experimental rhinovirus challenge revealed a loss of adaptive capacity in asthmatics, whose post-challenge state resembled other infected asthmatics more than their own pre-challenge state (p=0.029).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: